SCLN
Wells Fargo’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-55,139
| Closed | -$618K | – | 6190 |
|
|
2017
Q3 | $618K | Sell |
55,139
-4,082
| -7% | -$45.8K | ﹤0.01% | 4107 |
|
|
2017
Q2 | $651K | Sell |
59,221
-122,271
| -67% | -$1.34M | ﹤0.01% | 3960 |
|
|
2017
Q1 | $1.78M | Buy |
181,492
+36,034
| +25% | +$353K | ﹤0.01% | 3270 |
|
|
2016
Q4 | $1.57M | Buy |
145,458
+125,406
| +625% | +$1.35M | ﹤0.01% | 3296 |
|
|
2016
Q3 | $206K | Sell |
20,052
-268
| -1% | -$2.75K | ﹤0.01% | 4309 |
|
|
2016
Q2 | $265K | Sell |
20,320
-3,795
| -16% | -$49.5K | ﹤0.01% | 4123 |
|
|
2016
Q1 | $265K | Buy |
24,115
+1,131
| +5% | +$12.4K | ﹤0.01% | 4116 |
|
|
2015
Q4 | $211K | Sell |
22,984
-36,131
| -61% | -$332K | ﹤0.01% | 4270 |
|
|
2015
Q3 | $410K | Sell |
59,115
-19,002
| -24% | -$132K | ﹤0.01% | 3946 |
|
|
2015
Q2 | $767K | Buy |
78,117
+20,288
| +35% | +$199K | ﹤0.01% | 3748 |
|
|
2015
Q1 | $512K | Buy |
57,829
+12,447
| +27% | +$110K | ﹤0.01% | 3850 |
|
|
2014
Q4 | $397K | Buy |
45,382
+18
| +0% | +$157 | ﹤0.01% | 3972 |
|
|
2014
Q3 | $313K | Sell |
45,364
-4,726
| -9% | -$32.6K | ﹤0.01% | 4075 |
|
|
2014
Q2 | $263K | Buy |
50,090
+5,046
| +11% | +$26.5K | ﹤0.01% | 4170 |
|
|
2014
Q1 | $205K | Hold |
45,044
| – | – | ﹤0.01% | 4247 |
|
|
2013
Q4 | $227K | Sell |
45,044
-25,278
| -36% | -$127K | ﹤0.01% | 4135 |
|
|
2013
Q3 | $356K | Sell |
70,322
-26,660
| -27% | -$135K | ﹤0.01% | 3884 |
|
|
2013
Q2 | $481K | Buy |
+96,982
| New | +$481K | ﹤0.01% | 3681 |
|